Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Botulinum toxin treatment of pain disorders / / Bahman Jabbari
| Botulinum toxin treatment of pain disorders / / Bahman Jabbari |
| Autore | Jabbari Bahman |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (438 pages) |
| Disciplina | 297.05 |
| Soggetto topico |
Botulinum toxin - Therapeutic use
Toxina botulínica Ús terapèutic |
| Soggetto genere / forma | Llibres electrònics |
| ISBN |
9783030996505
9783030996499 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- Chapter 1: The History of Botulinum Neurotoxin Development -- Introduction -- Biology and Basic Science -- Neurologists: Clinical Neurotoxicologists in the United States -- PREEMPT Group (Drs. Silberstien, Dodick, Aurora, Lipton, Blumenfeld, and Others) -- Germany -- Austria -- References -- Chapter 2: Molecular Structure, Mode of Action, Immunology, Safety, and Side Effects of BoNTs -- Introduction -- Structure of Botulinum Neurotoxin and Its Mode of Action -- Diffusion and Spread of Neurotoxins -- Immunology of BoNTs -- Side Effects of BoNTs -- References -- Chapter 3: Analgesic Effects of Botulinum Neurotoxins: Data from Animal Studies Volunteers -- Introduction -- Pathophysiology of Pain at Peripheral and Central Levels -- Pain Modulation -- Data from Animal Studies -- Effect of Botulinum Toxins on Pain Channels and Receptors -- Effect on Sodium Channels -- Effect on Transient Receptor Potentials (TRP) Channels -- Effect on Purinergic Channels -- The Role of Nerve Growth Factor (NGF) in Pain -- The Effects of Botulinum Toxins on Inflammation -- Spinal Cord Gabaergic Neurons and Pain: Effects of Botulinum Toxins -- Effects of Botulinum Toxins on Opioid Channels -- Opioid Receptors -- BoNT Effects on Nerve Regeneration and Nerve Recovery -- Evidence for Central Analgesic Effect of Botulinum Neurotoxins -- Additional Mechanisms Potentially Promoting the Analgesic Effects of BoNTs in Pain -- Conclusion -- References -- Chapter 4: Botulinum Toxin Therapy for Neuropathic Pain (NP) -- Neuropathic Pain: Definition and Pathophysiology -- Postherpetic Neuralgia (PHN) -- Treatment -- BoNT Studies in Postherpetic Neuralgia (PHN) -- Case Report -- Comment -- The Effect of Botulinum Toxin on Itch Associated with PHN -- Posttraumatic Neuralgia -- Treatment -- BoNT Treatment of Posttraumatic Neuralgia -- Case Report.
Metabolic and Drug-Induced Painful Peripheral Neuropathies -- Diabetic Neuropathy -- Pathophysiology -- Treatment of Painful Diabetic Neuropathy (PDN) -- BoNT Treatment in Diabetic Neuropathy -- Comment -- Painful Neuropathy Related to Drugs and Chemotherapeutic Agents -- Case Report -- Comment -- Complex Regional Pain Syndrome -- Pathophysiology -- Treatment of Complex Regional Pain Syndrome -- BoNT Treatment of CRPS -- Comment -- Residual Limb Pain and Phantom Pain -- Pharmacological Treatment -- BoNT Treatment of RLP and PLP -- Comment -- Chapter Conclusion -- References -- Chapter 5: Botulinum Toxin Treatment in Migraine and Other Headaches -- Migraine -- Introduction -- Treatment -- Therapeutic Use of Calcitonin Gene-Related Peptide (CGRP) Inhibitors -- Botulinum Neurotoxin for Preventive Treatment of Migraine -- Episodic Migraine (EM) -- Comment -- Chronic Migraine -- BoNT Injection Technique in Chronic Migraine -- Patient Report -- The Issue of Medication Overuse in Chronic Migraine -- Long-Term Response to BoNTs in Chronic Migraine and Safety Issues -- Imploding Versus Exploding Migraine -- BoNT Treatment in Pediatric Chronic Migraine -- Treatment of Chronic Migraine with Other Botulinum Toxins -- IncobotulinumtoxinA (Xeomin) -- The Mechanism of Action of OnabotulinumtoxinA (onaA) in Chronic Migraine -- Comparison of Botulinum Toxin Treatment and CGRP Treatment -- Comment -- Tension-Type Headache (TTH) -- Pathophysiology -- Treatment -- BoNT Treatment of Tension-Type Headache (TTH) -- Comment -- Chronic Daily Headaches (CDH) -- Trigeminal Autonomic Cephalalgias (TAC) -- Cluster Headaches -- Treatment -- BoNT Treatment of Cluster Headaches -- Posttraumatic Headaches (PTH) -- Botulinum Toxin Treatment of Posttraumatic Headaches -- Comment -- References -- Chapter 6: Botulinum Neurotoxins and Chronic Low Back Pain -- Introduction. Anatomy of Low Back Muscles -- Pathophysiology of Chronic Low Back Pain -- Medical Treatment of Chronic Low Back Pain -- Evidence for Efficacy of BoNTs in Chronic Low Back Pain -- Studies -- Case Report -- How Does the Administration of Botulinum Toxin Improve Low Back Pain? -- Comment -- References -- Chapter 7: Botulinum Toxin Treatment of Plantar Fasciitis (Plantar Fasciopathy) -- Introduction -- Anatomy of Plantar Fascia -- Pathophysiology of Plantar Fasciitis -- Treatment of Plantar Fasciitis -- BoNT Treatment of Plantar Fasciitis -- Case Report -- Comparator Studies -- How Does BoNT Injections Improve Pain in Plantar Fasciitis? -- Conclusion -- References -- Chapter 8: Botulinum Toxin Treatment of Myofascial Pain Syndrome and Fibromyalgia -- Introduction -- Anatomy and Pathophysiology of Myofascial Pain Syndrome (MFPS) -- Treatment -- BoNT Treatment of Myofascial Pain Syndrome (MPS) -- Double-Blind, Placebo-Controlled Studies -- Comparator Studies -- Case Reports -- Patient (8-1): Myofascial Pain Syndrome with Two Trigger Points in One Muscle -- Patient (8-2): Multiple Trigger Points in Multiple Muscles -- Comment on the Efficacy of BoNT Therapy in Myofascial Pain Syndrome -- The Mechanism of Action of BoNTs in Myofascial Pain Syndrome (MPS) -- Fibromyalgia -- Botulinum Toxin Treatment of Fibromyalgia -- Comment -- References -- Chapter 9: Botulinum Toxin Therapy for Pelvic and Urogenital Pain -- Introduction -- Anatomy of the Pelvic Floor -- Treatment of Chronic Pelvic Pain -- Botulinum Toxin Treatment of Chronic Pelvic Pain -- Rational -- Botulinum Neurotoxins Studies in Chronic Pelvic Pain (CPP) -- Comment -- Botulinum Toxin Treatment of Dyspareunia and Vaginismus -- Vulvodynia -- Comment -- Painful Bladder Disorders -- Botulinum Toxin Treatment of BPS/IC -- Injection Technique -- The Proposed Mechanisms of BoNT Action in Bladder Pain. Comment -- References -- Chapter 10: Botulinum Toxin Treatment of Chronic Facial Pain: Trigeminal Neuralgia and Temporo-Mandibular Disorders -- Trigeminal Neuralgia (TN) -- Treatment -- Pharmacologic Treatment -- Surgical Treatment -- Anatomy and Physiology of Trigeminal Sensory System -- Botulinum Toxin Treatment of Trigeminal Neuralgia -- Human Studies of BoNTs in Trigeminal Neuralgia -- Case Report -- Comment -- Temporomandibular Disorder (TMD) -- Treatment -- Botulinum Toxin Treatment of TMD -- Comment -- Case Report (10-2) -- References -- Chapter 11: Botulinum Neurotoxins for Relief of Pain Associated with Spasticity -- Introduction -- Pathophysiology of Spasticity and Spasticity Related Pain (SRP) -- Treatment of Spasticity -- Nonpharmacological Treatment of Spasticity -- Pharmacological Therapy -- Procedural Approaches and Surgical Interventions -- Botulinum Toxin Studies in Spasticity That Have Included Assessment of Pain -- Upper Limb Spasticity-Related Pain in Adults -- Comment -- Case 11-1 -- Lower Limb Spasticity-Related Pain of Adults -- Case 2 -- Comment -- Effects of BoNT Treatment on Pain of Children with Cerebral Palsy and Spasticity -- Comment -- The Mechanism of Action of BoNTs in Spasticity-Related Pain (SRP) -- Conclusion -- References -- Chapter 12: Treatment of Dystonic Pain with Botulinum Neurotoxins -- Introduction -- Cervical Dystonia -- Treatment -- Effects of BoNTs on Pain Associated with Cervical Dystonia -- Comparator Studies -- Same Toxin, Different Doses -- Different Toxins -- Comment -- Case 12.1 -- Botulinum Toxin Treatment of Painful Dystonia in Neurodegenerative Disorders -- Case 12-2 -- Case -12-3 -- Comment -- Post-traumatic Dystonia -- Case 12-4 -- Comment -- References -- Chapter 13: Botulinum Toxin Treatment of Piriformis Syndrome -- Introduction -- Anatomy -- Pathophysiology of the Piriformis Syndrome. Treatment of the Piriformis Syndrome (PS) -- Botulinum Toxin Treatment of Piriformis Syndrome -- Double-Blind, Placebo-Controlled Studies of BoNTs in Piriformis Syndrome -- Technical Points -- Comparator Studies -- The Mechanism of Botulinum Toxin Action in Piriformis Syndrome -- Conclusion -- References -- Chapter 14: Botulinum Toxin Therapy for Prevention of Postsurgical Pain -- Introduction -- Postmastectomy Breast Reconstruction -- Botulinum Toxin Treatment of Pain After Breast Reconstructive Surgery -- Comment -- Posthemorrhoidectomy Pain -- Treatment of Posthemorrhoidectomy Pain -- Botulinum Toxin Treatment of Posthemorrhoidectomy Pain -- Blinded, Placebo Controlled Studies -- Randomized, Controlled Study -- Prospective, Randomized Comparator Studies -- Comment -- Prevention and Reduction of Posthernia Repair Pain -- Reduction of Severe Pain After Adductor Release Surgery -- Conclusion -- References -- Chapter 15: Botulinum Toxins (BoNTs) for Treatment of Pain in Orthopedic Disorders -- Introduction -- Chronic Lateral Epicondylitis (CLE) -- Botulinum Neurotoxin Studies in CLE -- Placebo-Controlled Studies -- Comparator Studies -- Comment -- Introduction -- Botulinum Toxin Treatment -- Comparator Studies -- Comment -- Botulinum Neurotoxin Treatment after Total Knee Arthroplasty -- Knee Pain with Vastus Lateralis Imbalance -- Botulinum Toxin Treatment -- Comments on the Use of BoNT Injections for Pain After Knee Arthroplasty and Vastus Lateralis Imbalance (Patellofemoral Syndrome) -- References -- Chapter 16: Botulinum Toxin in Dentistry and Treatment of Chronic Orofacial Pain -- Introduction -- Chronic Orofacial Pain -- Musculoskeletal Orofacial Pain -- Temporomandibular Disorders (TMDs) -- Definition, Classification, and Epidemiology -- Management of Temporomandibular Disorders. Efficacy of BoNT in the Treatment of Temporomandibular Disorders with Pain. |
| Record Nr. | UNINA-9910574064703321 |
Jabbari Bahman
|
||
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cannabinoids and pain / / Samer N. Narouze, editor
| Cannabinoids and pain / / Samer N. Narouze, editor |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (xix, 339 pages) : illustrations (black and white) |
| Disciplina | 615.7827 |
| Soggetto topico |
Cannabinoids - Therapeutic use
Pain - Chemotherapy Cànnabis Ús terapèutic |
| Soggetto genere / forma | Llibres electrònics |
| ISBN |
9783030691868
3-030-69186-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Part I: Introduction to Cannabis -- 1: History of Cannabis -- 2: Cannabis Regulations -- Introduction -- Federal Regulations -- State Cannabis Laws -- Research Expansion -- Conclusion -- 3: The Demand for Medical Cannabis Education -- 4: Pain Physicians and Medical Cannabis: Attitudes, Believes, Preparedness and Knowledge -- Introduction -- Development and Description of the Applied Questionnaire -- Statistical Analysis -- Results -- Discussion -- Summary -- Medical Cannabis Questionnaire -- 5: Cannabis Terminology -- Introduction -- General Aspects of the Cannabis Plant -- Differences Between C. sativa and C. indica -- Cannabis Versus Hemp -- The Endocannabinoid System (ECS) -- Key Terminology -- Cannabis Products and Accessories -- Conclusion -- Part II: Cannabinoids Pharmacology -- 6: The Endocannabinoid System -- Introduction -- Brief History of Cannabis and Hemp -- Components of the Endocannabinoid System (ECS) -- eCBs and Their Signal Transduction Pathways -- Complexity of the Endogenous Cannabinoid System -- CB1 and CB2 Receptor -- Other Receptors -- Transporters -- Enzymes -- Physiological Actions of ECS -- 7: Cannabinoid Receptor 1 (CB1) -- CB1 Receptors -- CB1 Receptor Physiology, Pathology, and Pharmacology -- CB1 Signaling -- CB1 Receptor Distribution -- Neocortex -- Hippocampus -- Hypothalamic -- Midbrain Periaqueductal Gray -- Brain Stem Rostral Ventromedial Medulla -- Tolerance -- CB1 Receptor Ligands -- References -- 8: Cannabinoid Receptor 2 (CB2) -- Cannabinoid 2 Receptor -- CB2 Receptor Physiology and Pharmacology -- CB2 Receptor Distribution -- CB2 Signaling -- CB2 Chronic Pain Models -- Tolerance -- CB2 Receptor Ligands.
9: Endocannabinoids: Anandamide and 2-Arachidonoylglycerol (2-AG) -- Introduction -- Biosynthesis and Breakdown Pathways -- Anandamide -- 2-AG -- Endocannabinoids' Mechanism of Action -- Anandamide -- 2-AG -- Plasticity of Endocannabinoid Signaling -- Endocannabinoids in Pain -- Peripheral Mechanisms -- Spinal Mechanisms -- Supraspinal Mechanisms -- Conclusion -- 10: Phytocannabinoids: Tetrahydrocannabinol (THC) -- Phytocannabinoids -- Introduction -- Δ9-Tetrahydrocannabinol (THC) -- Mechanism of Action of THC -- Applied Pharmacology and Pharmacokinetics -- Absorption -- Smoking -- Oral -- Oro-mucosal and Intranasal -- Rectal -- Transcutaneous -- Distribution -- Metabolism and Elimination -- Conclusion -- 11: Phytocannabinoids: Cannabidiol (CBD) -- Phytocannabinoids -- Cannabidiol and Its Various Clinical Effects -- Pharmacodynamics of Cannabidiol -- Applied Pharmacology and Pharmacokinetics -- Smoking -- Oral -- Transcutaneous -- Volume of Distribution -- Metabolism -- Elimination -- Safety Profile and Side Effects -- Cannabidiol Interaction with Tetrahydrocannabinol -- Conclusion -- 12: Other Phytocannabinoids -- Introduction -- Synthesis of Phytocannabinoids -- Cannabinoids and the Endocannabinoid System (ECS) -- Minor Cannabinoids -- Cannabinol (CBN) -- Cannabigerol (CBG) -- Cannabichromene (CBC) -- Tetrahydrocannabivarin (THCV) -- Conclusion -- 13: Cannabis Drug Interactions -- Introduction -- Routes of Administration -- Cannabinoid Drug Interactions -- Specific Drug Interactions -- Over-the-Counter (OTC) Analgesics -- Neuropathic Agents -- Opiates -- Antiepileptics -- Psychotropics -- Anticoagulants and Antiplatelets: "Blood Thinners" -- Warfarin -- Direct Oral Anticoagulants -- Clopidogrel -- Heparin/Fondaparinux -- References -- Part III: Pharmaceutical Cannabinoids. 14: Dronabinol (Marinol®) -- Introduction -- Mechanism of Action -- Pharmacokinetics -- Therapeutic Use -- Safety, Toxicity, and Adverse Effects -- 15: Nabilone (Cesamet) -- Introduction -- Clinical Trials -- Pharmacology and Pharmacokinetics -- Dosage and Administration -- Monitoring, Adverse Events, Drug Interactions, and Abuse Potential -- Adverse Effects -- Drug Interactions -- Abuse Potential -- 16: Cannabidiol (Epidiolex) -- Introduction -- Clinical Trials -- Pharmacology and Pharmacokinetics -- Dosage and Administration -- Monitoring, Adverse Events, and Drug Interactions -- Adverse Effects -- Abuse Potential -- 17: Nabiximols (Sativex®) -- Introduction -- Nabiximols Production -- Nabiximols Approval and Indications -- Nabiximols Contraindication -- Nabiximols Evidence -- Nabiximols for MS-Related Spasticity -- Nabiximols for MS-Related Neuropathic Pain -- Nabiximols for Cancer-Related Pain -- Nabiximols for Chronic Pain -- Nabiximols Tolerability -- Nabiximols Dosage and Administration -- Administration -- Dosing -- Storage, Stability, and Dosage Form -- Storage and Stability -- Dosage Form -- Summary -- Part IV: Medical Cannabis -- 18: Cannabis Strains to Chemovars -- Introduction -- Cannabis sativa L. -- Cannabis Cultivation and Trichomes -- Importance of Trichomes -- Cannabis Constituents -- Cannabinoids -- Terpenoids -- Other Cannabis Compounds -- Entourage Effect of Cannabis Constituents -- Cannabis Classification: Strains Versus Chemovars -- Strains -- Chemovar -- Practical Chemovar Selection for Clinicians -- Summary -- 19: The Model of a Medical Cannabis Clinic -- Introduction -- Description of a Medical Cannabis Clinic -- Referral and Screening -- Initial Visit -- Follow-Up and Monitoring -- Patient Education and Physician Communication. Protocols and Procedure Guidelines -- Continuing Medical Education -- Research Development -- Conclusion -- References -- 20: Barriers for the Prescription of Cannabinoid-Based Medicines -- Introduction -- Barriers for Cannabinoid Prescription -- Social Stigma for the Use of Cannabis -- Myths Versus Realities of Medical Cannabis Use -- Research Gaps and Limitations to Justify Medical Cannabis Use -- Lack of Knowledge Regarding Cannabis Regulatory Frameworks -- Limited Medical Cannabis Education -- Development of Medical Cannabis Education Programs with High Scientific Content -- Conclusion -- 21: Practical Recommendations for the Use of Medical Cannabis -- Introduction -- Cannabinoid-Based Medicines: What Is Currently Available? -- Prescription or Pharmaceutical Cannabinoids -- Natural Cannabis -- Inhalation -- Practical Recommendations [11, 12] -- Oral Administration -- Practical Recommendations [11, 12] -- Therapeutic Properties of Cannabinoids: THC Versus CBD -- Practical Recommendations for the Prescription of Cannabinoid-Based Medicines -- Clinical Evidence to Support Cannabinoid Use in Specific Medical Conditions -- Is the Patient a Candidate for Cannabinoid Therapy? A Systematic Approach -- Conclusion -- 22: Cannabinoid-Based Medicines: Dosing, Titration & -- Monitoring -- Introduction -- Methods of Administration -- Inhalation: Smoking and Vaporizing -- Oral -- Oromucosal -- Topical -- Dosing -- Concentration and Potency -- Cannabis Flower Dosing -- Cannabis Oil Dosing -- Achieving Optimal Therapeutic Dose and Cannabis Rotation -- Cannabis Chemovar Rotation and Reduction -- Monitoring -- Summary -- 23: Cannabinoid-Based Medicines: Patient Safety Considerations -- Introduction -- Practical Considerations for Cannabis Use -- Considerations -- Immunocompromised Patients. Calcineurin Inhibitors, Protein Disulfide Isomerase (PD1) Inhibitors, and Biologics -- Chronic Kidney Disease -- Older Adults and Patients with Concurrent Medical Conditions -- Polypharmacy and Drug Interactions [10] -- Precautions -- Concurrent Active Mood or Anxiety Disorder -- Patients with Risk Factors for Cardiovascular Disease (CVD) -- Tobacco Use -- E-Cigarette Use -- Severe Liver Dysfunction or Disease -- Medications Associated with Sedation or Cognitive Impairment -- Driving and Safety Sensitive Occupations -- Relative Contraindications -- Individuals Under the Age of 25 -- Cannabis Use Disorder (CUD) -- Substance Use Disorder (SUD) and Consideration for Harm Reduction -- Contraindications -- Cardiovascular Disease -- Respiratory Disease -- Psychosis and Bipolar Disorders -- Pregnancy and Breastfeeding -- Summary -- Part V: Cannabinoids and Pain -- 24: Cannabinoids and Pain: Mechanisms of Action -- Introduction -- Endocannabinoids' Mechanism of Action -- Anandamide (AEA) -- 2-Arachidonoylglycerol (2-AG) -- Endocannabinoids and Pain Modulation -- Peripheral Mechanisms -- Spinal Mechanisms -- Supraspinal Mechanisms -- Anandamide and 2-AG Synergistic Effect -- Endocannabinoid Receptors -- CB1 Receptors -- Central CB1 Receptors -- Peripheral CB1 Receptors -- Central CB2 Receptors -- Peripheral CB2 Receptors -- Other Putative Endocannabinoid Receptors: TRPV1 and GPR55 -- TRPV1 -- GPR55 -- Phytocannabinoids (THC and CBD) -- THC -- CBD -- Mechanisms of Action in Pain Modulation -- THC -- CBD -- References -- 25: Cannabinoids and Pain: Clinical Evidence -- Introduction -- Chronic Non-cancer Pain -- Chronic Neuropathic Pain -- Fibromyalgia -- Rheumatoid Arthritis -- Cancer Pain -- Acute Nociceptive Pain -- Summary -- 26: Cannabinoids and Cancer Pain -- Introduction -- Relevant Mechanisms of Cancer Pain. Current Understanding of Clinical Studies. |
| Record Nr. | UNINA-9910488702303321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cannabis in Psychiatric Practice : A Practical Guide / / edited by Paula Riggs, Thida Thant
| Cannabis in Psychiatric Practice : A Practical Guide / / edited by Paula Riggs, Thida Thant |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (221 pages) |
| Disciplina | 616.8918 |
| Collana | Psychiatry Update |
| Soggetto topico |
Psychiatry
Cànnabis Ús terapèutic Malalties mentals Quimioteràpia Psicofarmacologia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-031-04874-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Public Health Concerns of Cannabis -- 2. Clinical Pharmacology of Cannabinoids -- 3. Cannabidiol: Overview, Complexities and Opportunities for Behavioral Health -- 4. Developmental Impact -- 5. Cannabis in the Child and Adolescent Outpatient Mental Health Setting -- 6. Cannabis in The Child and Adolescent Emergency and Inpatient Psychiatric Settings -- 7. Clinical Considerations for Cannabis in the Child and Adolescent Consultation-Liaison Setting -- 8. Disease course & prognosis -- 9. Evaluation of Co-occurring Psychiatric Disorders and Cannabis Use in the Outpatient Setting -- 10. Treatment of Co-occurring Psychiatric Disorders and Cannabis Use in the Outpatient Setting -- 11. Acute intoxication and agitation/violence -- 12. Cannabis and Psychosis -- 13. Self-Harm and Cannabis Use -- 14. Cannabis in the Adult Medical and Consultation-Liaison Settings -- 15. Cannabis in the Perinatal Period -- 16. Cannabis in the Geriatric Population -- 17. Marijuana Use in Organ Transplantation. |
| Record Nr. | UNINA-9910585770303321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cannabis Use in Medicine : A Concise Handbook / / edited by Rahim Valani
| Cannabis Use in Medicine : A Concise Handbook / / edited by Rahim Valani |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (164 pages) |
| Disciplina |
905
615.7827 |
| Collana | Medicine Series |
| Soggetto topico |
Therapeutics
Neurosciences Emergency medicine Neuroscience Emergency Medicine Cànnabis Ús terapèutic |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 9783031127229 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | PART 1 Introduction -- 1. Introduction and background of marijuana -- 2. Legal aspects of marijuana in North America and worldwide -- 3. Pharmacodynamics and pharmacokinetics of marijuana.-PART 2 Recreational and Medical Use.-4. Recreational use of marijuana -- 5. Medical use of marijuana in mental healthcare (anxiety, PTSD, bipolar disorder) -- 6. Medical use of marijuana in pain management syndromes -- 7. Medical use of marijuana for neurological disorders (seizure, MS, Alzheimer’s, Parkinsons) -- 8. Medical use of marijuana in GI disorders – IBD / Crohn’s -- 9. Medical use of marijuana in rheumatological disorders (Lupus).-10. Medical use of marijuana and future directions (glaucoma, immune modulation, cancer) -- 11. Medical management of acute complications. |
| Record Nr. | UNINA-9910619278803321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation / / edited by Azin Alizadehasl, Ardeshir Ghavamzadeh, Amir Hossein Emami, Ghasem Janbabaei, Davood Khoda-Amorzideh
| Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation / / edited by Azin Alizadehasl, Ardeshir Ghavamzadeh, Amir Hossein Emami, Ghasem Janbabaei, Davood Khoda-Amorzideh |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (289 pages) |
| Disciplina | 616.1 |
| Soggetto topico |
Cardiology
Cancer - Genetic aspects Cancer Genetics and Genomics Cardiologia Cèl·lules mare Ús terapèutic |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-031-53659-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | HSCT at a glance -- Burden of cardiovascular disease in HSCT -- Risk factors and Mechanisms of Cardiotoxicity in HSCT -- Cardiotoxicity of commonly used drugs in HSCT -- Pre-HSCT cardiovascular evaluation -- HSCT in low EF patients -- Arrhythmias and conduction disorders in HSCT -- Coronary and peripheral arterial disease in HSCT -- Thrombotic disease in HSCT -- Pulmonary hypertension in HSCT -- Pericardial disease in HSCT -- Metabolic syndrome in HSCT -- HSCT in patients with cardiac amyloidosis -- HSCT in patients with autoimmune conditions, sickle cell anaemia and thalassemia -- Cardiotoxicity surveillance and cardioprotective strategies in HSCT. |
| Record Nr. | UNINA-9910851984503321 |
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Dynamic Light Scattering Spectroscopy of the Human Eye / / by Jeffrey N. Weiss
| Dynamic Light Scattering Spectroscopy of the Human Eye / / by Jeffrey N. Weiss |
| Autore | Weiss Jeffrey N. |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (98 pages) |
| Disciplina |
880.9
617.71545 |
| Collana | Medicine Series |
| Soggetto topico |
Ophthalmology
Oftalmopaties Dispersió de la llum Ús terapèutic |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 9783031066245 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Anatomy of the eye -- Chapter 2. Light Scattering -- Chapter 3. Dynamic Light Scattering (DLS) -- Chapter 4. DLS – Animal Experiments -- Chapter 5. DLS – Human Experiments -- Chapter 6. DLS in Neurologic diseases - Protocol -- Chapter 7. DLS in Neurologic diseases – Informed Consent -- Chapter 8. Patents. . |
| Record Nr. | UNINA-9910616204603321 |
|
Weiss Jeffrey N.
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Engineered Nanomaterials for Innovative Therapies and Biomedicine / / edited by Hemen Sarma, Sonam Gupta, Mahesh Narayan, Ram Prasad, Anand Krishnan
| Engineered Nanomaterials for Innovative Therapies and Biomedicine / / edited by Hemen Sarma, Sonam Gupta, Mahesh Narayan, Ram Prasad, Anand Krishnan |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (463 pages) |
| Disciplina |
610.28
660.6 |
| Collana | Nanotechnology in the Life Sciences |
| Soggetto topico |
Nanotechnology
Nanomedicine Biomaterials Nanoparticles Nanobiotechnology Environmental engineering Biotechnology Bioremediation Nanomedicine and Nanotoxicology Biomedical Materials Environmental Engineering/Biotechnology Materials biomèdics Materials Ús terapèutic |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-82918-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface -- Engineered Nanomaterials for a Sustainable Future -- Advances in Nanomedicine Development for Head and Neck Cancer Therapy -- Nanoparticles Towards Advanced Cancer Therapeutics -- Quantum Dots and Progress in the Diagnosis and Treatment of Cancer -- Nanomaterial-Based Diagnosis of Prostate Cancer -- Nanomaterials for Treatment for Psoriasis vulgaris -- Nanomaterials for the Treatment of Neurodegenerative Diseases -- Nanomaterial Research Involving Neural Stem Cells and Tissue Engineering -- Metal Nanoparticles for Dermatology and Cosmetics -- Quantum Dots -- Development of Nanomaterials Based on Graphene for Biomedical Purposes -- Nanomaterials in Vaccines and Immunology -- Mesophorous Silica Nanomaterials Enhances Adhesion for Enduring Bacterial Inhibition -- Personalized Nanomedicine -- Nanotherapeutic Approach to Obesity Treatment -- Fluorescent Silicone Nanomaterials -- Nanomaterial-Based Electrochemical Screening Techniques for Endocrine-Disrupting Chemicals -- Polymersomes -- Development in Nanotechnology in the Manufacturing of Dental Materials -- Biomedical and Antioxidative Nanomaterials -- Emerging 2D Material-Based Bioelectronics and Biosensors -- Advances in Natural Polymer-Based Electrospun Nanomaterials for Soft Tissue Engineering -- Nano-Forensics -- Bibliography -- Index. |
| Record Nr. | UNINA-9910548171203321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fundamentals of Machine Learning and Deep Learning in Medicine / / by Reza Borhani, Soheila Borhani, Aggelos K. Katsaggelos
| Fundamentals of Machine Learning and Deep Learning in Medicine / / by Reza Borhani, Soheila Borhani, Aggelos K. Katsaggelos |
| Autore | Borhani Reza |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Springer Nature, 2022 |
| Descrizione fisica | 1 online resource (201 pages) |
| Disciplina |
006.31
610.285631 |
| Collana | Medicine Series |
| Soggetto topico |
Internal medicine
Machine learning Internal Medicine Machine Learning Aprenentatge automàtic Intel·ligència artificial Ús terapèutic |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-031-19502-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Mathematical Modeling of Medical Data -- Linear Learning -- Nonlinear Learning -- Multi-Layer Perceptrons -- Convolutional Neural Networks -- Recurrent Neural Networks -- Autoencoders -- Generative Adversarial Networks -- Reinforcement Learning. |
| Record Nr. | UNINA-9910631085603321 |
|
Borhani Reza
|
||
| Springer Nature, 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Healing Power of Touch – Guidelines for Nurses and Practitioners : External Applications in Pediatrics / / edited by Georg Seifert, Alfred Längler
| The Healing Power of Touch – Guidelines for Nurses and Practitioners : External Applications in Pediatrics / / edited by Georg Seifert, Alfred Längler |
| Edizione | [1st ed.. 2022.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (215 pages) |
| Disciplina | 615.852 |
| Collana | Medicine Series |
| Soggetto topico |
Nursing
Alternative medicine Pediatrics Complementary and Alternative Medicine Tacte Ús terapèutic Pediatria |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-85507-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface -- Chapter 1. Introduction: External applications -- Chapter 2. Factors of touch based external applications -- Chapter 3. The skin -- Chapter 4. Therapeutic effects and relations of external applications -- Chapter 5. Techniques of external applications -- Chapter 6. Instructions for external applications -- Chapter 7. Substances -- Chapter 8. Search register/Glossary. |
| Record Nr. | UNINA-9910523732603321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Journal of therapeutic ultrasound
| Journal of therapeutic ultrasound |
| Pubbl/distr/stampa | London : , : BioMed Central, , [2013]- |
| Descrizione fisica | 1 online resource |
| Disciplina | 616.07543 |
| Soggetto topico |
Diagnostic ultrasonic imaging
Ultrasonics in medicine Ultrasonic Therapy Ultrasonography Ultrasons Ús terapèutic |
| Soggetto genere / forma |
Periodical
Fulltext Internet Resources. Periodicals. Revistes electròniques. |
| ISSN | 2050-5736 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | JTU |
| Record Nr. | UNISA-996204504403316 |
| London : , : BioMed Central, , [2013]- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Soggetto topico
-
Ús terapèutic
(22)
- Cànnabis (5)
- Dermatology (3)
- Internal Medicine (3)
- Internal medicine (3)